Sign inGet started

PIERCE GLENN

Insider CIK 1256964 · GBT Director · VYGR Interim CSO, Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
VYGR Voyager Therapeutics, Inc. A Award deriv2026-06-092026-06-1130,000— $030,000SEC↗
VYGR Voyager Therapeutics, Inc. A Award deriv2025-06-032025-06-0424,000— $024,000SEC↗
VYGR Voyager Therapeutics, Inc. A Award deriv2024-06-052024-06-0724,000— $024,000SEC↗
VYGR Voyager Therapeutics, Inc. A Award deriv2023-06-062023-06-0722,000— $022,000SEC↗
GBT Global Blood Therapeutics, D To issuer deriv2022-10-052022-10-0615,000— $00SEC↗
GBT Global Blood Therapeutics, D To issuer deriv2022-10-052022-10-0615,000— $00SEC↗
GBT Global Blood Therapeutics, D To issuer deriv2022-10-052022-10-0615,000— $00SEC↗
GBT Global Blood Therapeutics, D To issuer deriv2022-10-052022-10-0615,000— $00SEC↗
GBT Global Blood Therapeutics, D To issuer deriv2022-10-052022-10-063,600— $00SEC↗
GBT Global Blood Therapeutics, D To issuer deriv2022-10-052022-10-067,500— $00SEC↗
GBT Global Blood Therapeutics, D To issuer deriv2022-10-052022-10-065,247— $00SEC↗
GBT Global Blood Therapeutics, D To issuer deriv2022-10-052022-10-065,600— $00SEC↗
GBT Global Blood Therapeutics, D To issuer deriv2022-10-052022-10-065,600— $00SEC↗
GBT Global Blood Therapeutics, D To issuer2022-10-052022-10-0626,437— $00SEC↗
VYGR Voyager Therapeutics, Inc. S Sale2022-07-142022-07-189,512$6.70 $63.7K16,788SEC↗
GBT Global Blood Therapeutics, A Award deriv2022-06-142022-06-163,600— $03,600SEC↗
GBT Global Blood Therapeutics, M Exercise deriv2022-06-142022-06-163,600— $00SEC↗
GBT Global Blood Therapeutics, A Award deriv2022-06-142022-06-165,600— $05,600SEC↗
GBT Global Blood Therapeutics, M Exercise2022-06-142022-06-163,600— $026,437SEC↗
VYGR Voyager Therapeutics, Inc. A Award deriv2022-06-062022-06-0822,000— $022,000SEC↗
VYGR Voyager Therapeutics, Inc. A Award deriv2022-01-132022-01-1850,000— $050,000SEC↗
VYGR Voyager Therapeutics, Inc. A Award2022-01-132022-01-1826,300— $026,300SEC↗
GBT Global Blood Therapeutics, A Award deriv2021-06-172021-06-213,600— $03,600SEC↗
GBT Global Blood Therapeutics, A Award deriv2021-06-172021-06-215,600— $05,600SEC↗
GBT Global Blood Therapeutics, M Exercise deriv2021-06-172021-06-213,037— $00SEC↗
GBT Global Blood Therapeutics, M Exercise2021-06-172021-06-213,037— $022,837SEC↗
VYGR Voyager Therapeutics, Inc. A Award deriv2021-06-072021-06-0842,000— $042,000SEC↗
VYGR Voyager Therapeutics, Inc. A Award deriv2021-06-032021-06-0450,000— $050,000SEC↗
GBT Global Blood Therapeutics, M Exercise deriv2020-09-102020-09-1415,000— $015,000SEC↗
GBT Global Blood Therapeutics, M Exercise2020-09-102020-09-1415,000$15.03 $225.4K19,800SEC↗
GBT Global Blood Therapeutics, M Exercise deriv2020-06-172020-06-194,800— $00SEC↗
GBT Global Blood Therapeutics, A Award deriv2020-06-172020-06-195,247— $05,247SEC↗
GBT Global Blood Therapeutics, A Award deriv2020-06-172020-06-193,037— $03,037SEC↗
GBT Global Blood Therapeutics, M Exercise2020-06-172020-06-194,800— $04,800SEC↗
VYGR Voyager Therapeutics, Inc. A Award deriv2020-06-042020-06-0515,000— $015,000SEC↗
GBT Global Blood Therapeutics, A Award deriv2019-06-182019-06-204,800— $04,800SEC↗
GBT Global Blood Therapeutics, A Award deriv2019-06-182019-06-207,500— $07,500SEC↗
VYGR Voyager Therapeutics, Inc. A Award deriv2019-06-132019-06-1715,000— $015,000SEC↗
VYGR Voyager Therapeutics, Inc. P Buy2018-09-122018-09-125,000$18.44 $92.2K5,000SEC↗
GBT Global Blood Therapeutics, A Award deriv2018-06-202018-06-2215,000— $015,000SEC↗
VYGR Voyager Therapeutics, Inc. A Award deriv2018-06-142018-06-1815,000— $015,000SEC↗
VYGR Voyager Therapeutics, Inc. A Award deriv2017-06-292017-06-3015,000— $015,000SEC↗
GBT Global Blood Therapeutics, A Award deriv2017-06-202017-06-2215,000— $015,000SEC↗
VYGR Voyager Therapeutics, Inc. A Award deriv2017-01-032017-01-0530,000— $030,000SEC↗
GBT Global Blood Therapeutics, A Award deriv2016-06-162016-06-1715,000— $015,000SEC↗
GBT Global Blood Therapeutics, A Award deriv2016-02-082016-02-1030,000— $030,000SEC↗